- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Past Events
DIA 2019 Global Annual Meeting in San Diego
May 16, 2019 | 1:00 PM to 3:30 PM
FDA White Oak Campus Building 31, Room 1503 - Great Room
Annual Public Meeting Set for May 2, 2019
Executive Director June Wasser will present Collecting Data from EA Treatment for Regulatory Submissions at the Life Science Compassionate Access Summit at 4:00 pm, Monday, March 18th in Philadelphia.
The Reagan-Udall Foundation for the FDA honored two longtime U.S.
See Event Highlights and Download the Meeting Report
Expanded access programs, sometimes also called “compassionate use” programs, provide patients with serious or immediately life-threatening diseases or conditions access to investigational products outside of clinical tria
Palvella Therapeutics recently attended the FDA’s public meeting on the initiative held on October 28th in partnership with the Reagan-Udall Foundation.
Last month, the FDA took a bold leap forward by launching the Rare Disease Framework Initiative with a public meeting that included feedback from 75 members of the rare disease community; I was honored to participate in this meeting, and we will be using the input from it to shape and strengthen the initiative... .
On August 5, 2026, FDA and the Reagan-Udall Foundation for the FDA convened a public meeting on drug repurposing.